Description
A selective, orally bioavailable inhibitor of JNK1, JNK2, and JNK3 (IC50s = 80, 90, and 230 nM, respectively); induces regression of endometriotic lesions without suppressing estrogen action in animal models of endometriosis
Formal name: α-[2-[[4-(4-morpholinylmethyl)phenyl]methoxy]-4-pyrimidinyl]-2-benzothiazoleacetonitrile
Synonyms: AS-602801
Molecular weight: 457.5
CAS: 848344-36-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|JNK||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cancer Stem Cell Research|Proliferation||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|Cell Signaling|JNK Signaling||Research Area|Cell Biology|Cell Signaling||Research Area|Immunology & Inflammation|Adaptive Immunity